Aviana Sinar Abadi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Aviana Sinar Abadi Tbk. trades at Rp294 (market cap 1.66T, 124.08M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Aviana Sinar Abadi Tbk. is far larger — about 9.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Aviana Sinar Abadi Tbk. is more actively traded (124.08M versus 96.7K). Which is the better fit depends on your goals.
| IRSX | OBAT | |
|---|---|---|
Market Cap | 1.66T | 167.37B |
Volume | 124.08M | 96.7K |
Lot | 1.24M | 967 |
Turnover | 35.62B | 23.82M |
Average Price | 287.1 | 246.34 |
Value | 35.62B | 23.82M |
Indicative Equilibrium Price | 294 | 248 |
Indicative Equilibrium Volume | 14.62K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Aviana Sinar Abadi Tbk (the Company) was established on December 17, 2013 based on Notarial Deed No. 15 of Isadora, S.H., M.Kn., notary in Jakarta. The Company started its commercial operations in 2013.
Read more on IRSX →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →